Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area

European Journal of Immunology

Volumn 31, Issue 2, 2001, Pages 539-550

  Jouin, Hélène ^a   Rogier, Christophe ^b   Trape, Jean François ^c   Mercereau Puijalon, Odile ^a  

^a INSTITUT PASTEUR   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Antibody; Antigen, peptide, epitope; Human; Infectious immunity parasites; Protozoan parasite

Indexed keywords

ANTIBODY; EPITOPE; HLA ANTIGEN; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; PEPTIDE; RECOMBINANT PROTEIN;

AGE; ALLELE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; FOLLOW UP; GENETIC POLYMORPHISM; GENOME IMPRINTING; GENOTYPE; HEALTH SURVEY; HLA TYPING; HUMAN; LONGITUDINAL STUDY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN; SEROPREVALENCE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; EPITOPES; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; SEROEPIDEMIOLOGIC STUDIES; VACCINES, SYNTHETIC;

EID: 0035107412     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200102)31:2<539::AID-IMMU539>3.0.CO;2-1     Document Type: Article

References (29)

1. Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein
2. Antigens induced on erythrocytes by P. falciparum: Expression of diverse and conserved determinants
3. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria
4. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)
5. Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum
6. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan
7. Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions
8. Naturally acquired immunity to Plasmodium falciparum
9. Association of malaria parasite population structure, HLA, and immunological antagonism
10. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum
11. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and pre-dominantly of the immunoglobulin G3 subclass
12. Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum
13. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp 190 and control of malarial infections
14. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain-specific and short-lived
15. A principal target of human immunity to malaria identified by molecular population genetic and immunological analysis
16. The Dielmo project: A longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal
17. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1
18. Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait
19. HLA-A, -B, -C, -DR, -DQ typing in a population group of Senegal: Distribution of HLA antigens and HLA-DRB1*13 and DRB1*11 subtyping by PCR using sequence-specific primers (PCR-SSP)
20. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission
21. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes
22. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages
23. High annual and seasonal variations in malaria transmission by anophelines and vector species composition in Dielmo, a holoendemic area in Senegal
24. B-cell abnormalities in AIDS: Stable and clonally-restricted antibody response in HIV-1 infection
25. Deceptive imprinting in the immune response against HIV-1
26. Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: High prevalence of a third polymorphic form detected in strains derived from malaria patients
27. Human malaria parasites in continuous culture
28. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
29. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria